Theme: Novel Treatment Methods for Infectious Diseases Prevention, Control and Cure

Infectious Diseases 2017
Past Report of Infectious Diseases 2016

Infectious Diseases 2017

Track 01: Types of Infectious Diseases

The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 02: Causes and Symptoms of Infectious Diseases

Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 03: Global Trends in Emerging Infectious Diseases

An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 04: Microbial Pathogenesis and Virulence

Microbial pathogenesis is the study of the molecular mechanisms used by microorganisms to cause disease in humans and animals. By understanding how pathogens cause disease helps in the development of new therapeutic approaches. Virulence is the measure of the pathogenicity of an organism. The degree of virulence is related directly to the ability of the organism to cause infection despite host resistance mechanisms, it is affected by numerous variables such as the number of infecting bacteria, route of entry into the body, specific and nonspecific host defence mechanisms and virulence factors of the bacterium. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 05: Immunology of Infections

Immunology of infections means the battle between pathogens and the host immune defences. Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity. Immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 06: Mechanism of Resistance

Mechanism of resistance towards antimicrobials by microorganisms includes the following mechanisms of enzymatic destruction, enzymatic modification, altered target and decreased uptake. Mechanism of resistance is due to the inactivation or modification of antibiotics, an alteration in the target site of the antibiotic that reduces its binding capacity, the modification of metabolic pathways to circumvent the antibiotic effect and the reduced intracellular antibiotic accumulation by decreasing permeability and/ or increasing active efflux of the antibiotic. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 07: Antimicrobial/ Antibiotic/ Antibacterial Resistance

Antimicrobial/ antibiotic/ antibacterial resistance is the ability of microorganisms to resist the effects of drugs that means diseases causing germs do not get killed and their growth is not stopped.  Antibiotic resistant infections are of greater risk which cannot be avoided completely. Infections with resistant organisms are difficult to treat requiring costly and sometimes toxic alternatives.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 08: Antimicrobial/ Antibiotic/ Antibacterial Stewardship

Antimicrobial/ antibiotic/ antibacterial stewardship promotes the appropriate use of antimicrobials which improves patient outcomes reduces microbial resistance and decreases the spread of infections caused by multidrug resistant organisms.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 09: Epidemiology of Emerging and Re-Emerging Infectious Diseases

Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 10: Diagnosis of Infectious Diseases

Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 11: Treatment for Infectious Diseases

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 12: Infectious Diseases Prevention, Control and Cure

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 13: Antimicrobials/ Antibiotics/ Antibacterials

Antimicrobials/ antibiotics/ antibacterials are the drugs used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Few antibiotics possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza and their inappropriate use allows the emergence of resistant organisms.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 14: Vaccines and Vaccination

Vaccines are the products that are able to produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 15: Infectious Diseases Vaccines

Infectious diseases vaccines are the vaccines which prevent the infectious diseases and infectious diseases like diphtheria, haemophilus influenzae serotype b infection, hepatitis b, measles, meningitis, mumps, pertussis, poliomyelitis, rubella, tetanus, tuberculosis and yellow fever are preventable through vaccines.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 16: Sexually Transmitted Diseases/ Sexually Transmitted Infections

Sexually transmitted diseases/ sexually transmitted infections are the infectious diseases which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 17: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 18: Neuro Infectious Diseases

Neuro infectious diseases are the infectious diseases which are observed in the nervous system. Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuro immune disorder is multiple sclerosis and hiv is the most common viral infection of the nervous system.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 19: Noscomial Infections/ Hospital Acquired Infections/ Health Care Associated Infections

Nosocomial infections/ hospital acquired infections/ health care associated infections are the infections that are contracted from the environment or staff of a healthcare facility and they spread in the hospital environment, nursing home environment, rehabilitation facility and clinic or other clinical settings.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 20: Blood Stream Infections/ Bacteraemia/ Septicaemia/ Blood Poisoning

Blood stream infections/ bacteraemia/ septicaemia/ blood poisoning occurs when a bacterial infection elsewhere in the body such as in the lungs or skin which enters the blood stream. This is dangerous because the bacteria and their toxins can be carried through the blood stream to the entire body.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 21: Ebola and Zika Viral Infections

Ebola viral infection is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.  Zika virus disease is caused by a virus transmitted primarily by aedes mosquitoes. People with zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain and malaise or headache.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 22: Urinary Tract Infections

Urinary tract infections are the infections which are observed in any part of the urinary system (kidneys, ureters, bladder and urethra). Mostly infections are observed in the lower urinary tract (bladder and urethra). Women are at greater risk than men.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 23: Surgical Site Infections

Surgical site infections are the infections which may occur within 30 days after the operation and are observed in the parts of skin and subcutaneous tissue of the incision.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 24: Sepsis/ Septicaemia

Sepsis/ septicaemia is a life threatening condition that arises when the body's response to infection injures its own tissues and organs and the signs and symptoms of sepsis include fever, increased heart rate, increased breathing rate, confusion, cough with pneumonia and painful urination with a kidney infection. Severe sepsis causes poor organ function or insufficient blood flow. Insufficient blood flow may be evident by low blood pressure, high blood lactate and low urine output. Septic shock means the low blood pressure which occurs due to sepsis that does not improve even after injecting reasonable amounts of intravenous fluids.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 25: Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 26: Hepatitis

Hepatitis is caused by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis may occur with limited or no symptoms but often leads to jaundice, poor appetite and malaise. Hepatitis is acute when it lasts less than six months and chronic when it persists longer. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 27: Malaria

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases it can cause yellow skin, seizures, comaor and even death.

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 28: Microbial Forensics and Molecular Basis of Bacteria

Microbial forensics and molecular basis of bacteria is defined as a scientific discipline which is used to analyse microorganism/ toxin release. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 29: Animal Infectious Diseases/ Zoonosis

Animal infectious diseases/ zoonosis are important threat to human health since the emergence of human diseases is dominated by zoonotic pathogens. Infectious diseases affect livestock and also wild animals focusing on characterizing the conditions for the pathogen spread and maintenance in the host population. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 30: Plant Disease Modelling and Parameter Estimation

Plant pathology is the study of diseases in plants caused by pathogens and environmental conditions. Organisms that cause infectious diseases include fungi, oomycetes, bacteria, viruses, viroids, virus like organisms, phytoplasmas, protozoa, nematodes and parasitic plants. Plant pathology also involves the study of pathogen identification, disease etiology, disease cycles, economic impact, plant disease epidemiology, plant disease resistance, how plant diseases affect humans and animals, pathosystem genetics and management of plant diseases. 

Related Conferences

4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 Spain, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

 

Conference Series LLC Conferences invites all the participants from all over the world to attend “3rd World Congress on Infectious Diseases” during August 21-23, 2017 in San Francisco, California, USA which includes prompt keynote presentations, special sessions, workshops, symposiums, oral talks, poster presentations and exhibitions. 

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases like Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals
  • Infectious Diseases Specialists
  • Infection Prevention and Infection Control Specialists

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

For Scientific Sessions please go through the link: http://infection.omicsgroup.com/call-for-abstracts.php

For Abstract Submission please go through the link: http://infection.omicsgroup.com/abstract-submission.php

 

 

 

 

 

 

 

 

 

 

 

Infectious Diseases Therapeutic Market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious Diseases Diagnostics Market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

Worldwide deaths due to Infectious Diseases

 

Current Outbreak

The deadliest Ebola outbreak in recorded history is happening right now. The outbreak is unprecedented both in the number of cases and in its geographic scope. And so far, it doesn't look like it's slowing down.

The outbreak has now hit three countries: Guinea, Sierra Leone, and Liberia. And the virus — which starts off with flu-like symptoms and often ends with horrific hemorrhaging — has infected about 600 people and killed an estimated 367 since this winter, according to the numbers on June 26 from the World Health Organization.

Members associated with Infectious Diseases

  1. Centre for Infectious Diseases and Policy includes 218 members
  2. Global Public Health is having 106913 members
  3. Members Pediatric Infectious Disease and Immunology has 3291 members
  4. European Society of Clinical Microbiology and Infectious Diseases has 3438 members
  5. Infectious Diseases Society has 707 members

Worldwide Data

  1. Worldwide members of Infectious are 3,683 members
  2. European Congress in Clinical Microbiology and Infectious Diseases is having 1,369 members
  3. National Foundation for Infectious Diseases has 365 members
  4. UNC Institute for Global Health & Infectious Diseases has237 members
  5. Cirion; bridging the gap in infectious diseases between science and society has55 members
  6. HIV/AIDS & Infectious Diseases has 85 members
  7. M.S. in Public Health Microbiology & Emerging Infectious Diseases has 44 members
  8. Infectious Diseases and Public Health (IDPH) Research Group has 45 members
  9. EUPHA Section Infectious diseases control has 38 members
  10. Center for Structural Genomics of Infectious Diseases (CSGID) has30 members
  11. LSHTM_Control of Infectious Diseases has 19 members

Societies and Associations related to Infectious Diseases

  1. Healthcare Infection Society
  2. European Society for Pediatric Infectious Diseases
  3. European Society of Clinical Microbiology and Infectious Diseases
  4. Infection Prevention Society
  5. British Society for Immunology
  6. British Infection Association
  7. British Infection Association
  8. European Society for pediatric Infectious diseases
  9. Health care Infection Society
  10. Worldwide societies for infectious diseases is about 150

Universities related to Infectious Diseases

  1. University of Cambridge
  2. Kings College of London
  3. London School of Hygiene and Tropical Medicine
  4. Imperial College London
  5. UCL Institute of Epidemiology and Health care
  6. University of Sheffeild
  7. Pediatric Infectious Diseases Society
  8. Columbia University
  9. University of Maryland
  10. Swedish Institute for Infectious Disease Control
  11. Uppsala University
  12. University of Gothenburg
  13. University of Otago
  14. Oslo University
  15. University of Pittsburgh
  16. Emory Health Sciences
  17. Queensland University of Technology
  18. University of Liverpool
  19. University of Colorado Denver
  20. Infectious Diseases Society of America
  21.  Medical College of Georgia at Georgia Regents   University

Market Analysis of Companies

Funding towards Infectious Diseases

NIH funding for Infectious Diseases

References

  1. http://www.mayoclinic.org/diseases-conditions/infectious-diseases/basics/definition/con-   20033534
  2. http://ije.oxfordjournals.org/content/32/5/684.full
  3. http://www.jblearning.com/samples/0763728799/28799_CH01_001_022.pdf
  4. https://www.research.olemiss.edu/UMQuest/2007/Winter/ThePowerOfPartnerships.html
  5. http://ije.oxfordjournals.org/content/32/5/684.full
  6. http://www.ncbi.nlm.nih.gov/books/NBK56579/
  7. http://www.nhshistory.net/voluntary_hospitals.html
  8. http://www.vox.com/2014/6/26/5839394/the-deadliest-ebola-outbreak-in-history-is-happening-right-now
  9. http://en.wikipedia.org/wiki/List_of_hospitals_in_England
  10. http://www.healthcare.bayer.com/scripts/pages/en/company/products/index.php
  11. http://kff.org/global-health-policy/fact-sheet/the-u-s-government-and-global-tuberculosis/
  12. http://report.nih.gov/categorical_spending.aspx
  13. Murray JM, Law MG, Gao Z, Kaldor JM. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int J Epidemiol 2003;32: 708–14.
  14. Law MG, Dore GJ, Bath N et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717–24.
  15. Lederberg J, Shope RE (eds). Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press, 1992.
  16. Watts S. Epidemics and History: Disease, Power and Imperialism.New Haven, Conn: Yale University Press; 1997
  17. Lee HSJ, ed. Dates in Infectious Diseases. Boca Raton, Fla: The Parthenon Publishing Group; 2000.
  18. Fears JR. The plague under Marcus Aurelius and the decline and fall of the Roman Empire. Infect Dis Clin North Am. 2004;18:65–77.
  19. Antonine plague. Wikipedia Web page. Available at: http://en.wikipedia.org/wiki/Antonine_Plague. Accessed Feb 22, 2006.
  20. Porter R, ed. Cambridge Illustrated History of Medicine. New York, NY: Cambridge University Press; 1996.
  21. Rosen G. A History of Public Health. Baltimore, Md: Johns Hopkins University Press; 1993.
  22. McNeill WH. Plagues and Peoples.New York, NY: Doubleday; 1977.
  23. Hirst LF. The Conquest of Plague. London, England: Oxford University Press; 1953.
  24. Duncan SR, Scott S, Duncan CJ. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation. J Med Genet. 2005; 42:205–208.
Infectious Diseases 2016

Infectious Diseases 2016 Past Conference Report

Sensing the raising importance of Infectious Diseases prevention, control, treatment and cure, Conference Series LLC hosted 2nd World Congress on Infectious Diseases (Infectious Diseases 2016), scheduled from August 24-26, 2016 in Philadelphia, USA with a theme “Fighting Infectious Diseases with Novel and Innovative Therapeutic Techniques”.  The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by Conference Series LLC received generous response from the Editorial Board Members of Conference Series LLC Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2016 from Conference Series LLC. The conference was marked with the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the three day event into the path of success with thought provoking keynote and plenary presentations.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Infectious Diseases Types
  • Global Trends in Emerging Infectious Diseases
  • Microbial Pathogenesis and Virulence
  • Ebola and Current Research
  • Pediatric Infectious Diseases
  • Immunology of Infections
  • Epidemiology of Emerging and Re Emerging Diseases
  • Diagnosis of Infectious Diseases
  • Treatment for Infectious Diseases
  • Infectious Diseases Prevention, Control Measures and Cure
  • Clinical Studies and Case Reports
  • Mechanism of Resistance
  • Tuberculosis
  • Hepatitis
  • Antibiotic Resistance

 

Infectious Diseases 2016 Proceedings

 

The conference was embarked with an opening ceremony followed by Keynote presentations, Special sessions, Workshop and a series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

 

1. Moderators

  • Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
  • Dr. Ashok Kapse, Mahavir Super Specialty Hospital, India

2. Session Chairs

  • Dr. Glenn S Tillotson, Cempra Pharmaceuticals, USA
  • Dr. Joanna Zajkowska, Medical University of Białystok, Poland
  • Dr. Francis J Castellino, University of Notre Dame, USA
  • Dr. Eugenie Bergogne-Berezin, Centre Hospitalo-Universitaire Bichat-Claude Bernard University Diderot, France
  • Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
  • Dr. Rachel Groppo, Sanofi Pasteur, USA

 

3. Poster Judges

  • Dr. Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
  • Dr. Maria Luisa G Daroy, St. Luke’s Medical Center, Philippines 

4. Workshop 

  • Title: “Dengue diagnosis and case management”

            Dr. Ashok Kapse, Mahavir Super Specialty Hospital, India

 

5. Keynote Presentations

 

  • Glenn S Tillotson, Cempra Pharmaceuticals, USA
  • Rachel Groppo, Sanofi Pasteur, USA
  • Thomas D Licker, Decontamination Professionals International, Infection Control Technologies, USA
  • Stef Stienstra, Dutch Armed Forces / Royal Dutch Navy, Netherlands
  • Francis J Castellino, University of Notre Dame, USA
  • Joanna Zajkowska, Medical University of Białystok, Poland
  • Eugenie Bergogne-Berezin, Centre Hospitalo-Universitaire Bichat- Claude Bernard University Diderot, France
  • Ashok Kapse, Mahavir Super Specialty Hospital, India
  • Lalit Garg, University of Malta, Malta
  • K C Santosh, University of South Dakota, USA

6. Young Researchers

  • Title: Leprosy and medical practitioners in Enugu, Southern Nigeria”

            Otache Adah Emmanuel, University of Nigeria, Nigeria

 

  • Title: “Investigation of the role of the sRNA RyhB in regulating the locus of enterocyte effacement pathogenicity Island in enteropathogenic Escherichia coli”

            Marisa Egan, Saint Joseph’s University, USA

 

7. Best Poster Awards

  • Title: Recurrent cardiac tamponade secondary to coxsackie B type 4

            Moamen AL Zoubi, Advocate Illinois Masonic Medical Center, USA

 

  • Title: Pediatric gastrointestinal basidiobolomycosis

            Mojdeh Habibi Zoham, Tehran University of Medical Sciences, Iran

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference Series LLC in supporting and making the conference a grandiose event.

Your rejoinder is our inspiration, keeping this motto in mind and being witnessed the triumph of Infectious Diseases 2016, Conference Series LLC is delighted to announce the next event, "3rd World Congress on Infectious Diseases" to be held during August 21-23, 2017, California, San Francisco, USA.

Let us meet again @ Infectious Disease 2017

 


Past Reports  Gallery  

Key Topics

  • Infectious Diseases Types
  • Causes and Symptoms of Infectious Diseases
  • Global trends in Emerging Infectious Diseases
  • Microbial Pathogenesis and Virulence
  • Immunology of Infections
  • Mechanism of Resistance
  • Antibiotic Resistance
  • Antimicrobial Stewardship
  • Epidemiology of Emerging and Re Emerging Diseases
  • Diagnosis of Infectious Diseases
  • Treatment for Infectious Diseases
  • Infectious Diseases Prevention, Control Measures and Cure
  • Antibiotics
  • Vaccines and Vaccination
  • Infectious Diseases Vaccines
  • Pediatric Infectious Diseases
  • Sexually Transmitted Diseases
  • Neuro Infectious Diseases
  • Urinary Tract Infections
  • Surgical Site Infections
  • Blood Stream Infections
  • Noscomial Infections/ Hospital Acquired Infections
  • Ebola and Zika Viral Infections
  • Tuberculosis
  • Hepatitis
  • Malaria
  • Sepsis
  • Microbial Forensics and Molecular Basis of Bacteria
  • Animal Infectious Diseases/ Zoonosis
  • Plant Disease Modelling and Parameter Estimation
  • Types of Infectious Diseases
  • Causes and Symptoms of Infectious Diseases
  • Global Trends in Emerging Infectious Diseases
  • Microbial Pathogenesis and Virulence
  • Immunology of Infections
  • Mechanism of Resistance
  • Antimicrobial/ Antibiotic/ Antibacterial Resistance
  • Antimicrobial/ Antibiotic/ Antibacterial Stewardship
  • Epidemiology of Emerging and Re-Emerging Infectious Diseases
  • Diagnosis of Infectious Diseases
  • Treatment for Infectious Diseases
  • Infectious Diseases Prevention, Control and Cure
  • Antimicrobials/ Antibiotics/ Antibacterials
  • Vaccines and Vaccination
  • Infectious Diseases Vaccines
  • Sexually Transmitted Diseases/ Sexually Transmitted Infections
  • Pediatric Infectious Diseases/ Childhood Infectious Diseases
  • Neuro Infectious Diseases
  • Noscomial Infections/ Hospital Acquired Infections/ Health Care Associated Infections
  • Blood Stream Infections/ Bacteraemia/ Septicaemia/ Blood Poisoning
  • Ebola and Zika Viral Infections
  • Urinary Tract Infections
  • Surgical Site Infections
  • Sepsis/ Septicaemia
  • Tuberculosis
  • Hepatitis
  • Malaria
  • Microbial Forensics and Molecular Basis of Bacteria
  • Animal Infectious Diseases/ Zoonosis
  • Plant Disease Modelling and Parameter Estimation

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 21-23, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Testimonials

Conferenceseries Destinations